Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.72 |
| ▸ | PKM | P14618 | 1/20 | 0.72 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.72 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.69 |
| ▸ | MET | P08581 | 6/20 | 0.68 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.68 |
| ▸ | STAT3 | P40763 | 2/20 | 0.60 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.60 |
| ▸ | PTGES | O14684 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.59 |
| ▸ | RELA | Q04206 | 1/20 | 0.59 |
| ▸ | FDPS | P14324 | 1/20 | 0.59 |
| ▸ | APP | P05067 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Sinapate SCHEMBL2517008 | 1.00 | CYP1A2 (0.74) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL7158939 | 0.93 | EPHX2 (0.69) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL19202508 | 0.92 | EPHX2 (0.63) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL11210444 | 0.90 | EPHX2 (0.61) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL11210454 | 0.90 | EPHX2 (0.61) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| Hydrochloric Acid SCHEMBL11212410 | 0.89 | EPHX2 (0.60) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL26740971 | 0.89 | APP (0.76) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| Hydrochloric Acid SCHEMBL11212432 | 0.89 | EPHX2 (0.60) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL30528017 | 0.88 | CYP1A2 (0.63) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 | |
| Methyl Sinapate SCHEMBL887912 | 0.87 | PTGS1 (0.60) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037498-A | Impact-resistant plastic composite material and preparation method thereof | 雄安立亚科技集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-113072602-B | Phenolic acid glycosyl ester and preparation method thereof | 广东省科学院化工研究所 | 2023-08-01 | — | — | CN | claimed |
| CN-122037498-A | Impact-resistant plastic composite material and preparation method thereof | 雄安立亚科技集团有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119235834-B | Application of sinapic acid and derivatives thereof in preparing medicines for preventing and/or treating methamphetamine addiction withdrawal | 中国药科大学 | 2025-10-31 | — | — | CN | disclosed |
| CN-119876216-A | Bacillus subtilis expression system for producing feruloyl esterase by fermentation and application thereof | 中国科学院上海高等研究院 | 2025-04-25 | — | — | CN | disclosed |
| CN-119235834-A | Application of sinapic acid and derivatives thereof in preparing medicines for preventing and/or treating methamphetamine addiction withdrawal | 中国药科大学 | 2025-01-03 | — | — | CN | disclosed |
| CN-119235834-A | Application of sinapic acid and derivatives thereof in preparing medicines for preventing and/or treating methamphetamine addiction withdrawal | 中国药科大学 | 2025-01-03 | — | — | CN | disclosed |
| CN-117794534-A | Compositions for modulating cortisol homeostasis and improving sleep quality and methods of use and preparation thereof | 尤尼根公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116769751-A | Trifunctional enzyme Bi76 with xylanase, glucanase and feruloyl esterase activities and application thereof | 广州中医药大学(广州中医药研究院) | 2023-09-19 | — | — | CN | disclosed |
| CN-113072602-B | Phenolic acid glycosyl ester and preparation method thereof | 广东省科学院化工研究所 | 2023-08-01 | — | — | CN | disclosed |
| CN-116444461-A | Dibenzylbutane lignan LCA derivative and application thereof | 中国人民解放军海军军医大学 | 2023-07-18 | — | — | CN | disclosed |
| US-20110118345-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS, LLC | 2011-05-19 | — | — | US | disclosed |
| US-20110118345-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS, LLC | 2011-05-19 | — | — | US | disclosed |
| US-7943164-B2 | Contains quercetin, myricetin and chlorogenic acid; weight loss and weight control; inhibiting glucose absorption in the gut, enhancing glucose absorption by muscle tissue, inhibiting carbohydrate transport, inhibiting glucose/fat storage and inhibiting the manufacture of glucose by the liver | ATM METABOLICS, LLC | 2011-05-17 | — | — | US | disclosed |
| US-7943164-B2 | Contains quercetin, myricetin and chlorogenic acid; weight loss and weight control; inhibiting glucose absorption in the gut, enhancing glucose absorption by muscle tissue, inhibiting carbohydrate transport, inhibiting glucose/fat storage and inhibiting the manufacture of glucose by the liver | ATM METABOLICS, LLC | 2011-05-17 | — | — | US | disclosed |
| WO-2008115723-A1 | COMPOSITION FOR TREATING DIABETES AND METABOLIC DISORDERS WITH QUERCETIN, MYRCETIN AND CHLOROGENIC ACID | ATM METABOLICS LLLP (US) | 2008-09-25 | — | — | WO | disclosed |
| US-20080234364-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS, LLC | 2008-09-25 | — | — | US | disclosed |
| US-20080234364-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | ATM METABOLICS, LLC | 2008-09-25 | — | — | US | disclosed |
| US-7294369-B2 | Polymerisable cinnamates with lateral substitution | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2007-11-13 | — | — | US | disclosed |
| US-7294369-B2 | Polymerisable cinnamates with lateral substitution | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2007-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234364-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | PNLIP, CPT1B, LIPC | CYP1A2 624/4885CYP3A4 997/4885CYP2D6 677/4885 |
| US-20110118345-A1 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS | PNLIP, CPT1B, LIPC | CYP1A2 624/4885CYP3A4 997/4885CYP2D6 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.